Last reviewed: May 17, 2026

Last updated: May 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Shedrx and Henry Meds represent two distinct telehealth models for GLP-1 medication access, each with different clinical workflows, cost structures, and provider oversight approaches. Both operate through licensed pharmacies, but their eligibility criteria and prescription practices differ meaningfully.

Choosing between telehealth platforms involves more than comparing price and convenience. Understanding your own genetic predispositions in key peptide pathways, combined with biomarker assessment, can help you have a more informed discussion with your provider about which service aligns with your clinical needs.

Clinical Structure and Provider Oversight Models

Shedrx operates as a direct-to-consumer telehealth service with rapid provider consultations, typically resulting in same-day or next-day prescription issuance. Henry Meds integrates with a broader platform for sexual health and wellness, positioning GLP-1 as one option within a multi-specialty model. Both use licensed pharmacies, but their consultation depth and ongoing monitoring frameworks vary.

Provider oversight quality depends on consultation time, medical history review, and follow-up protocols. Longer initial consultations may allow providers to assess contraindications, comorbidities, and baseline metabolic markers more thoroughly. Neither platform guarantees superior clinical outcomes, but transparency about how much time your provider spends reviewing your case matters for informed decision-making.

Pricing, Pharmacy Access, and Coverage Transparency

Both Shedrx and Henry Meds offer compounded and branded GLP-1 options at varying price points. Shedrx typically ranges from $150–$300+ monthly depending on medication type and dosage. Henry Meds pricing is similarly variable. PlexusDx compounded semaglutide injection costs $149/mo and oral semaglutide from $249/mo, with compounded tirzepatide injection at $249/mo. Direct comparison requires reviewing each platform's current fee structure and pharmacy partnerships.

Factor Consideration
Medication Type Compounded vs. branded availability; semaglutide vs. tirzepatide vs. dual GLP-Squared formula
Monthly Cost Range Shedrx and Henry Meds vary by medication; PlexusDx compounded options start at $129–$309
Pharmacy Licensed Status Confirm all use licensed 503A compounding pharmacies, not 503B facilities
Insurance Coverage Telehealth platforms typically bill out-of-pocket; some coverage may apply with prior authorization
Follow-up Consultation Frequency Varies by platform; affects ability to adjust dosage and monitor for side effects

Genetic Predispositions and Medication Responsiveness

Individual response to GLP-1 medications varies significantly. Research identifies genetic variants in GLP1R, GIPR, FTO, and MC4R pathways that may correlate with metabolic phenotype and baseline appetite regulation. These predispositions do not determine exact medication response, but may help provide context for why one person experiences robust appetite suppression while another sees modest effects.

Understanding your genetic predispositions in these peptide pathways can support a more targeted conversation with your healthcare provider. PlexusDx Precision Peptide Genetic Test ($99 add-on or $298 standalone) reveals predispositions in key variants and can help inform whether medication choice, dosing strategy, or combination formulas align better with your biology.

Safety, Eligibility, and Who Should Seek Provider Evaluation

GLP-1 medications are contraindicated in personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, and certain other conditions. Both Shedrx and Henry Meds require baseline screening, but thoroughness depends on provider time and your complete health disclosure. Pancreatitis history, gallbladder disease, and diabetic retinopathy also require careful provider assessment before starting treatment.

Neither telehealth platform replaces comprehensive in-person evaluation for complex medical histories. If you have multiple comorbidities, take multiple medications, or have had prior adverse events with weight-loss interventions, discuss with a primary care provider or endocrinologist before initiating treatment—whether through Shedrx, Henry Meds, PlexusDx, or another service. Transparency about your full medical history with whichever provider you choose is essential for safety.

How PlexusDx Supports a More Personalized Approach

PlexusDx differs from Shedrx and Henry Meds by emphasizing how genetic predispositions in peptide pathways may help provide context for more personalized medication conversations. The Precision Peptide Genetic Test reveals variants in GLP1R, GIPR, FTO, and MC4R—regions implicated in appetite, glucose metabolism, and body weight regulation—allowing you and your provider to understand your baseline biology more clearly.

The genetic test does not predict your exact response to semaglutide, tirzepatide, or other GLP-1 medications. Instead, it should be interpreted with a qualified healthcare provider as one data point among many, including your metabolic markers, medical history, and clinical goals. Predispositions indicate biological tendency, not certainty of outcome.

By combining genetic insights with clinical assessment, you can engage in a more informed conversation about which medication, dosage, or formulation strategy may align best with your physiology. PlexusDx offers compounded semaglutide, tirzepatide, and dual-formula GLP-Squared options—all sourced from licensed 503A pharmacies—supporting a precision-wellness approach to GLP-1 treatment selection with your provider.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the main difference between Shedrx and Henry Meds?

Shedrx focuses on rapid GLP-1 prescription and delivery via telehealth, while Henry Meds offers GLP-1 within a broader sexual health and wellness platform. Both use licensed pharmacies, but consultation models and follow-up protocols differ. Neither guarantees superior clinical outcomes.

How do I know which telehealth GLP-1 service is right for me?

Consider consultation depth, pharmacy transparency, pricing, follow-up support, and whether your medical history requires more thorough initial screening. Discuss with your primary care provider if you have complex comorbidities. Different platforms suit different needs and clinical profiles.

What makes PlexusDx different from Shedrx and Henry Meds?

PlexusDx emphasizes genetic predisposition testing and biomarker context through the Precision Peptide Genetic Test. We source all compounded medications from licensed 503A pharmacies and focus on supporting provider-guided, personalized treatment conversations. Visit /products/genetic-test to learn more.

Does the Precision Peptide Genetic Test predict how I'll respond to GLP-1 medication?

No. The test reveals predispositions in peptide pathways—not exact medication response. Results should be interpreted with your healthcare provider as context for a more informed treatment discussion. Genetics is one factor among many influencing clinical outcomes.

Are Shedrx and Henry Meds medications FDA-approved?

Both platforms offer FDA-approved branded GLP-1 drugs and compounded versions. Compounded medications are not FDA-approved as individual products, but are prepared in licensed pharmacies under federal regulation. Ask your provider about the differences and confirm pharmacy licensing.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves